Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 1,1,1,3,3,3-hexafluoro-2-methylpropan-2-yl 4-((4-hydroxy-2-oxo-2h-1-benzopyran-3-yl)methyl)benzoate
2. Ati 5923
3. Ati-5923
4. Ati5923
1. 867257-26-9
2. Ati-5923
3. 1,1,1,3,3,3-hexafluoro-2-methylpropan-2-yl 4-((4-hydroxy-2-oxo-2h-chromen-3-yl)methyl)benzoate
4. Wn1479yt50
5. 1,1,1,3,3,3-hexafluoro-2-methylpropan-2-yl 4-[(4-hydroxy-2-oxo-2h-chromen-3-yl)methyl]benzoate
6. Benzoic Acid, 4-((4-hydroxy-2-oxo-2h-1-benzopyran-3-yl)methyl)-, 2,2,2-trifluoro-1-methyl-1-(trifluoromethyl)ethyl Ester
7. Tecarfarin [usan]
8. Tecarfarin [usan:inn]
9. Unii-wn1479yt50
10. Tecarfarin [inn]
11. Tecarfarin (usan/inn)
12. Tecarfarin [who-dd]
13. Schembl1647984
14. Chembl2105664
15. Ati5923
16. Dtxsid90235788
17. Ati 5923
18. Bcp31892
19. Db12823
20. Sb18978
21. (1,1,1,3,3,3-hexafluoro-2-methylpropan-2-yl) 4-[(4-hydroxy-2-oxochromen-3-yl)methyl]benzoate
22. Hy-14854
23. Cs-0003597
24. D09676
25. Ati-5923; Ati 5923; Ati5923
26. 257h269
27. Q27292724
28. 1,1,1,3,3,3-hexafluoro-2-methylpropan-2-yl4-((4-hydroxy-2-oxo-2h-chromen-3-yl)methyl)benzoate
29. 2,2,2-trifluoro-1-methyl-1-(trifluoromethyl)ethyl 4-((4-hydroxy-2-oxo-2h-1-benzopyran-3-yl)methyl)benzoate
30. 2,2,2-trifluoro-1-methyl-1-(trifluoromethyl)ethyl 4-((4-hydroxy-2-oxo-2h-chromen-3-yl)methyl)benzoate
31. Benzoic Acid, 4-[(4-hydroxy-2-oxo-2h-1-benzopyran-3-yl)methyl]-, 2,2,2-trifluoro-1-methyl-1-(trifluoromethyl)ethyl?ester
| Molecular Weight | 460.3 g/mol |
|---|---|
| Molecular Formula | C21H14F6O5 |
| XLogP3 | 5.5 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 11 |
| Rotatable Bond Count | 5 |
| Exact Mass | 460.07454252 g/mol |
| Monoisotopic Mass | 460.07454252 g/mol |
| Topological Polar Surface Area | 72.8 Ų |
| Heavy Atom Count | 32 |
| Formal Charge | 0 |
| Complexity | 750 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Tecarfarin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Tecarfarin, including repackagers and relabelers. The FDA regulates Tecarfarin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Tecarfarin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Tecarfarin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Tecarfarin supplier is an individual or a company that provides Tecarfarin active pharmaceutical ingredient (API) or Tecarfarin finished formulations upon request. The Tecarfarin suppliers may include Tecarfarin API manufacturers, exporters, distributors and traders.
click here to find a list of Tecarfarin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Tecarfarin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Tecarfarin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Tecarfarin GMP manufacturer or Tecarfarin GMP API supplier for your needs.
A Tecarfarin CoA (Certificate of Analysis) is a formal document that attests to Tecarfarin's compliance with Tecarfarin specifications and serves as a tool for batch-level quality control.
Tecarfarin CoA mostly includes findings from lab analyses of a specific batch. For each Tecarfarin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Tecarfarin may be tested according to a variety of international standards, such as European Pharmacopoeia (Tecarfarin EP), Tecarfarin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Tecarfarin USP).
LOOKING FOR A SUPPLIER?
